Stratec SE (Stratec SE) Common Stock : $13.22 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Stratec SE Common Stock?

Stratec SE's quarterly common stock increased from Sep. 2023 ($12.98 Mil) to Dec. 2023 ($13.26 Mil) but then declined from Dec. 2023 ($13.26 Mil) to Mar. 2024 ($13.22 Mil).

Stratec SE's annual common stock declined from Dec. 2021 ($13.70 Mil) to Dec. 2022 ($12.88 Mil) but then increased from Dec. 2022 ($12.88 Mil) to Dec. 2023 ($13.26 Mil).

Stratec SE Common Stock Historical Data

The historical data trend for Stratec SE's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stratec SE Common Stock Chart

Stratec SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

13.37

14.72

13.70

12.88

13.26

Stratec SE Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															13.02	13.17	12.98	13.26	13.22

Stratec SE Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Stratec SE (Stratec SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (OTCPK:SBMDY) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

SBS:Germany

Address

Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217

Website

https://www.stratec.com

Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.

Stratec SE (Stratec SE) Headlines

From GuruFocus

STRATEC SE: STRATEC Further Expands Its Presence in USA By Acquiring Natech Plastics

By ACCESSWIRE ACCESSWIRE • 06-07-2023